封面
市场调查报告书
商品编码
1747502

蛋白质定序市场按技术、产品、应用、最终用户和地区划分

Protein Sequencing Market, By Technology, By Product, By Application, By End User, By Region

出版日期: | 出版商: Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3个工作天内

价格
简介目录

蛋白质定序市场规模预计在 2025 年为 23.9 亿美元,预计到 2032 年将达到 53.2 亿美元,2025 年至 2032 年的复合年增长率为 12.1%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 23.9亿美元
效能数据 2020-2024 预测期 2025-2032
预测期:2025-2032年复合年增长率: 12.10% 2032年价值预测 53.2亿美元

蛋白质定序是生物化学和分子生物学领域中用于确定蛋白质中胺基酸顺序的重要技术。这个过程有助于理解蛋白质的结构和功能,而蛋白质的结构和功能对于各种生物过程至关重要。蛋白质定序在药物研究、生物技术和个人化医疗中发挥着至关重要的作用。

由于对蛋白质疗法的需求不断增长、蛋白质组学研究的进展以及慢性病盛行率的上升,全球蛋白质定序市场正在经历显着增长。此外,对精准医疗和个人化治疗的日益关注也推动了市场的成长。例如,2023年9月12日,专注于加速蛋白质体学发展的Olink Holding AB公司宣布与Eurofins Scientific Group旗下的Eurofins Genomics公司建立合作伙伴关係,透过应用Olink技术增强其在研究、人口健康和监管临床试验领域的服务。

同样,2022 年 3 月,药物发现和开发的下一代蛋白质组学解决方案领导者 Biognosys 宣布推出扩展的蛋白质组学平台套件,为製药和诊断客户提供从早期发现到临床的整个研发开发平臺的深入生物学见解。

市场动态:

蛋白质定序市场受多种因素驱动。首先,癌症、心血管疾病和神经系统疾病等慢性疾病的日益普及推动了对基于蛋白质的疗法的需求。蛋白质定序在药物开发中起着关键作用,使研究人员能够了解疾病机制并开发标靶治疗。例如,根据美国美国七分之一的成年人(约3,550万人,占14%)患有慢性肾臟病(CKD)。 65岁以上族群(34%)的CKD发生率高于45至64岁族群(12%)及18至44岁族群(6%)。

此外,蛋白质体学研究的进展也为蛋白质定序市场带来了新的机会。质谱和新一代定序等高通量技术的发展彻底改变了蛋白质体学领域,使蛋白质定序变得更加便捷和高效。

然而,蛋白质定序市场也面临挑战与限制。蛋白质定序仪器和试剂的高成本是市场成长的主要阻碍因素之一。此外,蛋白质结构的复杂性和多变性也为准确可靠的蛋白质定序带来了技术挑战。

然而,蛋白质定序市场仍存在许多成长机会。研发投入的增加,尤其是在新兴经济体,可能会为市场相关人员带来新的视野。此外,个人化医疗和标靶治疗的需求日益增长,预计将在未来推动蛋白质定序的需求。

本研究的主要特点

  • 本报告对全球蛋白质定序市场进行了详细分析,包括预测期为 2025 年至 2032 年的市场规模和年复合成长率(CAGR),以 2024 年为基准年。
  • 它揭示了不同细分市场中的潜在商机,并向相关人员提供了一系列有吸引力的投资提案。
  • 它提供了有关市场驱动因素、限制因素、市场机会、市场趋势以及蛋白质测序市场主要企业采用的竞争策略的重要见解。
  • 全球蛋白质定序市场的主要企业是根据公司亮点、产品系列、财务表现和策略等参数进行的分析。
  • 主要公司包括安捷伦科技、赛默飞世尔科技、SGS SA、岛津製作所、沃特世公司、Bio-Rad Laboratories、布鲁克公司、Charles River Laboratories、Selvita 和 Rapid Novor Inc.
  • 本研究报告将使负责人和管理机构能够就未来的产品发布、市场扩张和行销策略做出明智的决策。
  • 蛋白质定序产业的各个相关人员,如投资者、供应商、产品製造商、经销商、新进业者和金融分析师都可以从所提供的见解中受益。
  • 用于分析全球蛋白质定序市场的策略矩阵将有助于相关人员做出明智的决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章市场动态、法规与趋势分析

  • 市场动态
    • 驱动程式
    • 增加蛋白质体学研究的投资
    • 限制因素
    • 蛋白质定序设备和服务高成本
    • 机会
    • 新兴国家存在着巨大的成长机会
  • 影响分析
  • 主要亮点
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 併购场景

4. 蛋白质定序市场(依技术划分),2020 年至 2032 年

  • 艾德曼劣化
  • 质谱法
  • 其他的

5. 2020 年至 2032 年蛋白质定序市场(依产品划分)

  • 装置
  • 试剂、套件及耗材
  • 软体与服务

6. 蛋白质定序市场(依应用划分),2020 年至 2032 年

  • 学术研究
  • 临床诊断
  • 生物製药
  • 其他的

7. 2020 年至 2032 年蛋白质定序市场(依最终使用者划分)

  • 製药和生物技术公司
  • 学术和研究机构
  • 合约研究组织

8. 蛋白质定序市场(依地区划分),2020 年至 2032 年

  • 北美洲
      • 美国
      • 加拿大
  • 欧洲
      • 英国
      • 德国
      • 法国
      • 义大利
      • 西班牙
      • 俄罗斯
      • 其他欧洲国家
  • 亚太地区
      • 中国
      • 印度
      • 日本
      • 澳洲
      • 韩国
      • ASEAN
      • 其他亚太地区
  • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
      • 其他拉丁美洲
  • 中东
      • GCC
      • 以色列
      • 其他中东地区
  • 非洲
      • 北非
      • 中部非洲
      • 南非

第九章 竞争态势

  • Agilent Technologies
  • Thermo Fisher Scientific
  • SGS SA
  • Shimadzu Corp
  • Waters Corp.
  • Bio-Rad Laboratories
  • Bruker Corporation
  • Charles River Laboratories
  • Selvita
  • Rapid Novor Inc.

第 10 章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6507

Protein Sequencing Market is estimated to be valued at USD 2.39 Bn in 2025 and is expected to reach USD 5.32 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 12.1% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 2.39 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 12.10% 2032 Value Projection: USD 5.32 Bn

Protein sequencing is a crucial technique used in the field of biochemistry and molecular biology to determine the order of amino acids in a protein. This process helps in understanding the structure and function of proteins, which are essential in various biological processes. Protein sequencing plays a significant role in pharmaceutical research, biotechnology, and personalized medicine.

The global protein sequencing market has been witnessing significant growth due to the increasing demand for protein-based therapeutics, advancements in proteomics research, and the rising prevalence of chronic diseases. Moreover, the increasing focus on precision medicine and personalized treatments is also driving the market growth. For instance, on September 12 2023, Olink Holding AB, a company dedicated to accelerating proteomics, announced the collaboration with Eurofins Genomics, a division of Eurofins Scientific Group, to bolster its offerings in the fields of research, population health, and regulated clinical trials through the application of Olink technology.

Similarly, in March 2022, Biognosys, a leader in next-generation proteomics solutions for drug discovery and development, announced the launch of its expanded suite of proteomics platforms that provide pharmaceutical and diagnostics customers with deep biological insights across the entire R&D pipeline, from early stage discovery to clinical settings.

Market Dynamics:

The protein sequencing market is driven by several factors. Firstly, the growing prevalence of chronic diseases, such as cancer, cardiovascular diseases, and neurological disorders, has led to an increased demand for protein-based therapies. Protein sequencing plays a critical role in drug discovery and development, enabling researchers to understand the mechanisms of diseases and develop targeted therapies. For instance, according to data published by Centers for Disease Control and Prevention, more than 1 in 7 US adults-about 35.5 million people, or 14%-are estimated to have Chronic Kidney Disease (CKD). CKD is more common in people aged 65 years or older (34%) than in people aged 45-64 years (12%) or 18-44 years (6%).

Additionally, the advancements in proteomics research have opened up new opportunities for the protein sequencing market. The development of high-throughput technologies, such as mass spectrometry and next-generation sequencing, has revolutionized the field of proteomics, making protein sequencing more accessible and efficient.

However, there are certain challenges and restraints faced by the protein sequencing market. The high cost of protein sequencing instruments and reagents is one of the major hindrances to the market growth. Moreover, the complexity and variability of protein structures pose technical challenges in accurate and reliable protein sequencing.

Nevertheless, the protein sequencing market presents several opportunities for growth. The increasing investment in research and development activities, particularly in emerging economies, is likely to create new prospects for market players. Additionally, the rise in personalized medicine and the need for targeted therapies are expected to drive the demand for protein sequencing in the future.

Key Features of the Study:

  • This report provides in-depth analysis of the global protein sequencing market, including market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, with 2024 as the base year.
  • It elucidates potential revenue opportunities across different market segments and presents attractive investment proposition matrices for stakeholders.
  • The study provides key insights into market drivers, restraints, opportunities, market trends, and competitive strategies adopted by key players in the protein sequencing market.
  • Key players in the global protein sequencing market are profiled based on parameters such as company highlights, product portfolios, financial performance, and strategies.
  • The key companies covered in this study include Agilent Technologies, Thermo Fisher Scientific, SGS S.A., Shimadzu Corp, Waters Corp., Bio-Rad Laboratories, Bruker Corporation, Charles River Laboratories, Selvita, and Rapid Novor Inc.
  • The report enables marketers and management authorities to make informed decisions regarding future product launches, market expansion, and marketing tactics.
  • Various stakeholders in the protein sequencing industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts, can benefit from the insights provided.
  • Strategy matrices used in analyzing the global protein sequencing market will assist stakeholders in making informed decisions.

Protein Sequencing Market Segmentation:

  • By Technology
    • Edman Degradation
    • Mass Spectrometry
    • Others
  • By Product
    • Instruments
    • Reagents, Kits & Consumables
    • Software & Services
  • By Application
    • Academic Research
    • Clinical Diagnosis
    • Biopharmaceuticals
    • Others
  • By End user
    • Pharmaceutical & Biotechnology Companies
    • Academic & Research Institutes
    • Contract Research Organizations
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
  • Top Companies in Protein Sequencing Market:
    • Agilent Technologies
    • Thermo Fisher Scientific
    • SGS S.A.
    • Shimadzu Corp
    • Waters Corp.
    • Bio-Rad Laboratories
    • Bruker Corporation
    • Charles River Laboratories
    • Selvita
    • Rapid Novor Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Protein Sequencing, By Technology
    • Market Protein Sequencing, By Product
    • Market Protein Sequencing, By Application
    • Market Protein Sequencing, By End user
    • Market Protein Sequencing, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Increasing investments in proteomics research
    • Restraints
    • High costs of protein sequencing instruments and services
    • Opportunities
    • Significant growth opportunities exist in emerging economies
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Protein Sequencing Market, By Technology, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Edman Degradation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Mass Spectrometry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

5. Protein Sequencing Market, By Product, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
  • Reagents, Kits & Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
  • Software & Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)

6. Protein Sequencing Market, By Application, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Academic Research
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
  • Clinical Diagnosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
  • Biopharmaceuticals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)

7. Protein Sequencing Market, By End user, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Pharmaceutical & Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
  • Academic & Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)
  • Contract Research Organizations
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Billion)

8. Protein Sequencing Market, By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2023and 2032 (%)
    • Y-o-Y Growth Analysis, For Country 2021 - 2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End user, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End user, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • U.K
      • Germany
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End user, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End user, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End user, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End user, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Agilent Technologies
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • SGS S.A.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Shimadzu Corp
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Waters Corp.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bio-Rad Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bruker Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Charles River Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Selvita
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Rapid Novor Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us